Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

How Oncology Pharmacists Can Improve Care Quality

J Oncol Pract; ePub 2018 Jan 3; Vulaj, et al

Oncology pharmacists can improve oncology care quality as part of the clinical team by impacting certain quality measures, researchers concluded after conducting a recent analysis. Investigators analyzed 177 Quality Oncology Practice Initiative measures to determine which ones would most benefit from pharmacist involvement. Among the results:

  • 4 in every 10 of the metrics were potential areas of pharmacist impact.
  • Most of the identified measures related to optimizing drug therapy through development/implementation of pharmacy guidelines.
  • Specifically, they tended to deal with patient counseling and symptom management.
  • Several of the relevant measures overlap with those used for CMS’s Merit-Based Incentive Payment System.

Vulaj V, Hough S, Bedard L, Farris K, Mackler E. Oncology pharmacist opportunities: Closing the gap in quality care. [Published online ahead of print January 3, 2018]. J Oncol Pract.


This Week's Must Reads

Risk categories predict mRCC survival, Rini B et al. Clin Genitourin Cancer. 2018 May 3. doi: 10.1016/j.clgc.2018.04.005.

Access to care linked to better outcomes in black men with prostate cancer, Halabi et al, George et al. ASCO 2018 (annual meeting of the American Society of Clinical Oncology) Abstracts LBA5005 and LBA5009.

Prostate cancer before age 55 more likely in black men, Nettey OS et al. AUA 2018 (American Urological Association annual meeting). Abstract MP 21-17.

Statins may affect prostate cancer microenvironment, Allott E et al. AUA 2018 (annual meeting of the American Urological Association), Abstract MP21-01.

Prostate cancer risks higher in smokers, Foerster B et al. JAMA Oncol. 2018 May 24. doi: 10.1001/jamaoncol.2018.1071.

Must Reads in Practice Management

Colorectal cancer costs twice as much in US as Canada, Yezefski et al. ASCO 2018 Abstract LBA3579.

Flat pricing of ibrutinib , Sales revenues at the potential expense of patient safety

Most oncologists discuss medical marijuana with patients, Braun I et al. J Clin Oncol. 2018 May 10. doi: 10.1200/JCO.2017.76.1221.

$800M cut proposed for Centers for Medicare & Medicaid Innovation, Proposed rescission of budget authority

Medicare Beneficiary Identifiers required for billing by 2019, New Medicare cards